Recently, the sexually stimulating capsules, named VidaGra, have been introduced on the market. Offering a good alternative for a greatly needed and wanted product, like VIAGRA, is no problem, as long as it is marketed under a clearly different trademark. This way the consumer will not be confused, competition will cause quality to improve and prices to go down. Nevertheless, this case is a clear case of infringement of trademark rights, taking advantage of the possibly embarrassed consumers. Hopefully, Pfizer will put an end to this.
